早期的外周血液和骨髓MRD作为四倍治疗多发性骨髓瘤的预后标志物
Benjamin A Derman1, Jennifer Cooperrider1, Anna Pula1,2
1University of Chicago Chicago Illinois USA.
HemaSphere
|August 21, 2025
概括
No abstract available in PubMed .
更多相关视频
07:53Interphase Fluorescence in situ Hybridization of Bone Marrow Smears of Multiple Myeloma
Published on: April 15, 2022
4.3K
09:01Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
14.1K
